FDA Inspection
Sandoz Private LimitedSandoz Private Limited – FDA Inspection, Mar 3, 2017
Record Details
This FDA Inspection record concerns Sandoz Private Limited, with an inspection on March 3, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- jose a lopez rubet (Investigator)
- Reba A. Gates (Issuing Officer)
View Company Profile
ID · 9229958d-9cf3-4090-8c3f-9c2ef06e0fcd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1006673
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Sandoz Private Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 21, 2026 | Not classified | Office of Inspections and Investigations | |
| July 2, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 27, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 12, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 29, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sandoz Private Limited
- FDA Inspection 1338540 - 2026-08-21
- FDA Inspection 1241485 - 2024-07-02
- FDA Inspection 1137294 - 2020-02-27
- FDA Inspection 1086018 - 2019-04-12
- FDA Inspection 893384 - 2014-08-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.